Strides Pharma Secures USFDA Approval for Generic GERD Treatment
22 May 2024
Strides Pharma Science Limited announced on Wednesday that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has obtained approval from the United States Food & Drug Administration (USFDA) for its generic version of Sucralfate Oral Suspension, 1gm/10 mL. The company stated that this product is both bioequivalent...
Read More
